ArticlePharmacoEconomics - open2017
Model Registration: A Call to Action.
Article in PharmacoEconomics - open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Retractions of Health Economic Evaluations: A Systematic Review.PharmacoEconomics - open · 2026Pooled it
- Simulation modeling validity and utility in colorectal cancer screening delivery: A systematic review.Journal of the American Medical Informatics Association : JAMIA · 2020Pooled it
- Developing an Online Infrastructure to Enhance Model Accessibility and Validation: The Peer Models Network.PharmacoEconomics · 2022Article
- A meta-epidemiological assessment of transparency indicators of infectious disease models.PloS one · 2022Article
- Economic evaluation of meningococcal vaccines: considerations for the future.The European journal of health economics : HEPAC : health economics in prevention and care · 2020Article
- Registered Reports: Time to Radically Rethink Peer Review in Health Economics.PharmacoEconomics - open · 2020Article
- Check Your Checklist: The Danger of Over- and Underestimating the Quality of Economic Evaluations.PharmacoEconomics - open · 2019Article
- Publication of Decision Model Source Code: Attitudes of Health Economics Authors.PharmacoEconomics · 2019Article
- Can You Repeat That? Exploring the Definition of a Successful Model Replication in Health Economics.PharmacoEconomics · 2019Review
- The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.PharmacoEconomics · 2019Article
- Transparency in Decision Modelling: What, Why, Who and How?PharmacoEconomics · 2019Review
- A Need for Change! A Coding Framework for Improving Transparency in Decision Modeling.PharmacoEconomics · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.